Luca Maini

Harvard Medical School

Boston, MA

United States

  • Harvard Medical School

SCHOLARLY PAPERS

6

DOWNLOADS

2,281

TOTAL CITATIONS

5

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Demand Inertia and the Hidden Impact of Pharmacy Benefit Managers

Management Science, 0[10.1287/mnsc.2021.03331]
Number of pages: 70 Posted: 28 Jan 2019 Last Revised: 18 Nov 2024
Josh Feng and Luca Maini
University of Utah - David Eccles School of Business and Harvard Medical School
Downloads 725 (75,831)

Abstract:

Loading...

Drug Pricing, Pharmacy Benefit Managers, Formulary Design, Dynamic Games, Dynamic Pricing, Consumer Inertia

2.

Biosimilar Entry and the Pricing of Biologic Drugs

Number of pages: 40 Posted: 01 Feb 2021 Last Revised: 18 Nov 2024
Luca Maini, Josh Feng, Thomas Hwang and Jacob Klimek
Harvard Medical School, University of Utah - David Eccles School of Business, Harvard University - Brigham and Women's Hospital and University of North Carolina at Chapel Hill
Downloads 500 (121,105)
Citation 1

Abstract:

Loading...

Biosimilars, Drug Pricing, Generic Drugs

3.

Mergers that Matter: The Impact of M&A Activity in Prescription Drug Markets

Number of pages: 67 Posted: 08 Aug 2023
Josh Feng, Thomas Hwang, Yunjuan Liu and Luca Maini
University of Utah - David Eccles School of Business, Harvard University - Brigham and Women's Hospital, University of North Carolina (UNC) at Chapel Hill - Department of Economics and Harvard Medical School
Downloads 375 (169,287)
Citation 1

Abstract:

Loading...

Mergers and Acquisitions, Drug Pricing, Pharmaceutical Industry, Antitrust, Bargaining

4.

Reference Pricing as a Deterrent to Entry: Evidence from the European Pharmaceutical Market

Number of pages: 52 Posted: 04 Nov 2020 Last Revised: 03 Dec 2020
Luca Maini and Fabio Pammolli
Harvard Medical School and Polytechnic University of Milan - Department of Management, Economics and Industrial Engineering
Downloads 307 (210,470)

Abstract:

Loading...

external reference pricing, moment inequality, pharmaceutical market

5.

Profiting from Most-Favored Customer Procurement Rules: Evidence from Medicaid

American Economic Journal: Economic Policy, volume 15, issue 2, 2023[10.1257/pol.20200688]
Number of pages: 40 Posted: 20 Mar 2020 Last Revised: 18 Nov 2024
Josh Feng, Thomas Hwang and Luca Maini
University of Utah - David Eccles School of Business, Harvard University - Brigham and Women's Hospital and Harvard Medical School
Downloads 223 (290,701)
Citation 2

Abstract:

Loading...

Medicaid, Pharmaceutical Market, Bargaining, Most-Favored Customer Clauses, Procurement

6.

Stocking Under the Influence: Spillovers from Commercial Drug Coverage to Medicare Utilization *

Number of pages: 50 Posted: 17 Oct 2023
Emma Boswell Dean, Josh Feng and Luca Maini
Dartmouth College - Dartmouth Institute for Health Policy and Clinical Practice, University of Utah - David Eccles School of Business and Harvard Medical School
Downloads 151 (412,968)
Citation 1

Abstract:

Loading...

Drug Insurance, Hospitals, Medicare